|

Development of a New Method for Liver Stiffness Measurement Using FibroScan

RECRUITINGN/ASponsored by Echosens
Actively Recruiting
PhaseN/A
SponsorEchosens
Started2024-11-08
Est. completion2026-10-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06519331

Summary

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
* Adult patient able to give his written consent
* Patient affiliated to the French Social Security system

Exclusion Criteria:

* Vulnerable patients
* Patients with liver ascites
* Patients with heart failure

Conditions2

Liver DiseaseLiver Diseases

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.